Recent Quarter Total Invested
$280.54 M
Recent Quarter Institutional Ownership Percentage
76.2%
Total Invested of Last Quarter
$185.08 M
Ownership Percentage of Last Quarter
77.77%
Sutro Biopharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 7.19 M | $24.87 M | -6.76% | 8.76% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.02 M | $24.28 M | 100.00% | 8.55% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 3.00 M | $10.37 M | -32.61% | 3.65% |
BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.83 M | $9.80 M | -6.94% | 3.45% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.25 M | $7.79 M | 12.51% | 2.74% |
SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 2.20 M | $7.60 M | 0.00% | 2.68% |
CITADEL ADVISORS LLC | 11/14/2024 | 2.13 M | $7.36 M | 31.28% | 2.59% |
KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 2.07 M | $7.15 M | 2.11% | 2.52% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.03 M | $7.03 M | -53.42% | 2.48% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.86 M | $6.43 M | 7.65% | 2.26% |
EVERSEPT PARTNERS, LP | 11/14/2024 | 1.84 M | $6.37 M | 5.91% | 2.25% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.75 M | $6.04 M | 66.41% | 2.13% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 1.72 M | $5.94 M | -4.27% | 2.09% |
STATE STREET CORP | 11/14/2024 | 1.65 M | $5.70 M | 5.23% | 2.01% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.61 M | $5.57 M | 2.22% | 1.96% |
BAILLIE GIFFORD & CO | 11/05/2024 | 1.52 M | $5.26 M | -17.82% | 1.85% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.20 M | $4.15 M | 32.49% | 1.46% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 980,318 | $3.39 M | -9.67% | 1.19% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 828,097 | $2.87 M | 15.09% | 1.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 821,746 | $2.84 M | -21.75% | 1.00% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 814,955 | $2.85 M | 100.00% | 0.99% |
AQUILO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 762,498 | $2.64 M | 0.00% | 0.93% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 737,670 | $2.55 M | 5,299.82% | 0.90% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 590,900 | $2.04 M | -13.93% | 0.72% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 491,765 | $1.70 M | -2.35% | 0.60% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 437,051 | $1.51 M | 100.00% | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 359,919 | $1.25 M | 100.00% | 0.44% |
UBS OCONNOR LLC | 11/14/2024 | 338,222 | $1.17 M | 22.96% | 0.41% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 329,579 | $1.14 M | 0.00% | 0.40% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 325,538 | $1.13 M | 14.82% | 0.40% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 283,600 | $981,256 | -55.28% | 0.35% |
MORGAN STANLEY | 11/14/2024 | 274,085 | $948,337 | -4.77% | 0.33% |
BARCLAYS PLC | 11/19/2024 | 273,019 | $944,000 | 385.26% | 0.33% |
FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 271,337 | $938,826 | 0.00% | 0.33% |
LPL FINANCIAL LLC | 11/08/2024 | 269,899 | $933,851 | 17.27% | 0.33% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 251,995 | $871,903 | 16.22% | 0.31% |
PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 244,809 | $847,039 | -73.02% | 0.30% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 215,049 | $744,070 | -21.15% | 0.26% |
OMERS ADMINISTRATION CORP | 11/13/2024 | 190,300 | $658,438 | 100.00% | 0.23% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 182,226 | $630,502 | 0.45% | 0.22% |
D. E. SHAW & CO., INC. | 11/14/2024 | 167,645 | $580,052 | 30.30% | 0.20% |
UBS GROUP AG | 11/14/2024 | 165,859 | $573,872 | 429.02% | 0.20% |
MAN GROUP PLC | 11/14/2024 | 163,928 | $567,191 | 25.83% | 0.20% |
STRS OHIO | 11/01/2024 | 152,800 | $528,688 | -7.56% | 0.19% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 151,221 | $523,225 | 17.93% | 0.18% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 129,152 | $446,866 | 35.25% | 0.16% |
SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 128,850 | $445,821 | 575.56% | 0.16% |
RHUMBLINE ADVISERS | 11/12/2024 | 119,378 | $413,038 | 2.82% | 0.15% |
XTX TOPCO LTD | 11/14/2024 | 104,200 | $360,532 | 222.04% | 0.13% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 99,200 | $343,232 | -49.31% | 0.12% |
Sutro Biopharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of STRO shares?
During the previous two years, 145 institutional investors and hedge funds held shares of Sutro Biopharma, Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.19 M
BlackRock Funding, Inc. /DE: 7.02 M
Point72 Asset Management, L.P.: 3 M
BioImpact Capital LLC: 2.83 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.25 M
Samsara BioCapital, LLC: 2.2 M
-
What percentage of Sutro Biopharma, Inc. stock is owned by institutional investors?
76.20% of Sutro Biopharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at STRO ?
Institutional investors have bought a total of 64.85 M shares in the last 24 months. This purchase volume represents approximately $162.77 M in transactions.